158 related articles for article (PubMed ID: 2411137)
21. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72).
Klug TL; Sattler MA; Colcher D; Schlom J
Int J Cancer; 1986 Nov; 38(5):661-9. PubMed ID: 2429934
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA.
Ricolleau G; Chatal JF; Fumoleau P; Kremer M; Douillard JY; Curtet C
Tumour Biol; 1984; 5(3-4):151-9. PubMed ID: 6594738
[TBL] [Abstract][Full Text] [Related]
23. Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serum.
Boerman OC; Thomas CM; Segers MF; Kenemans P; Lövgren T; Zurawski VR; Haisma HJ; Poels LG
Clin Chem; 1987 Dec; 33(12):2191-4. PubMed ID: 2446805
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.
Davis HM; Zurawski VR; Bast RC; Klug TL
Cancer Res; 1986 Dec; 46(12 Pt 1):6143-8. PubMed ID: 2430690
[TBL] [Abstract][Full Text] [Related]
25. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma.
Ward BG; Cruickshank DJ; Tucker DF; Love S
Br J Obstet Gynaecol; 1987 Jul; 94(7):696-8. PubMed ID: 2441739
[TBL] [Abstract][Full Text] [Related]
26. CA125 antigen levels in obstetric and gynecologic patients.
Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
[TBL] [Abstract][Full Text] [Related]
27. OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
Xu FJ; Yu YH; Daly L; DeSombre K; Anselmino L; Hass GM; Berchuck A; Soper JT; Clarke-Pearson DL; Boyer C
J Clin Oncol; 1993 Aug; 11(8):1506-10. PubMed ID: 8336189
[TBL] [Abstract][Full Text] [Related]
28. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
29. Expression of CA 125 in adenomyosis.
Kijima S; Takahashi K; Kitao M
Gynecol Obstet Invest; 1987; 23(2):122-3. PubMed ID: 3472995
[TBL] [Abstract][Full Text] [Related]
30. Clinical correlations of ovarian cancer antigen NB/70K: a preliminary report.
Dembo AJ; Chang PL; Urbach GI
Obstet Gynecol; 1985 May; 65(5):710-4. PubMed ID: 3856794
[TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of the CA 125 tumor-associated antigen from human ascites.
de los Frailes MT; Stark S; Jaeger W; Hoerauf A; Wildt L
Tumour Biol; 1993; 14(1):18-29. PubMed ID: 7684153
[TBL] [Abstract][Full Text] [Related]
32. CA-125 in gynecological malignancies.
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
[TBL] [Abstract][Full Text] [Related]
33. CA-125 levels in endometriosis.
Patton PE; Field CS; Harms RW; Coulam CB
Fertil Steril; 1986 Jun; 45(6):770-3. PubMed ID: 2423378
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody assays for measuring ovarian tumor antigen in blood. Detection of NB/70K in patients with ovarian cancer and nongynecologic diseases.
Knauf S
Cancer; 1988 Sep; 62(5):922-5. PubMed ID: 3409174
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of serum CA 125 levels in the monitoring of ovarian cancer.
Vergote IB; Børmer OP; Abeler VM
Am J Obstet Gynecol; 1987 Jul; 157(1):88-92. PubMed ID: 2440307
[TBL] [Abstract][Full Text] [Related]
36. Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer.
Rubin SC; Finstad CL; Hoskins WJ; Provencher D; Federici MG; Lloyd KO; Lewis JL
Am J Obstet Gynecol; 1991 Feb; 164(2):558-63. PubMed ID: 1704184
[TBL] [Abstract][Full Text] [Related]
37. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma.
Bast RC; Siegal FP; Runowicz C; Klug TL; Zurawski VR; Schonholz D; Cohen CJ; Knapp RC
Gynecol Oncol; 1985 Sep; 22(1):115-20. PubMed ID: 2410329
[TBL] [Abstract][Full Text] [Related]
38. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
Bast RC; Klug TL; St John E; Jenison E; Niloff JM; Lazarus H; Berkowitz RS; Leavitt T; Griffiths CT; Parker L; Zurawski VR; Knapp RC
N Engl J Med; 1983 Oct; 309(15):883-7. PubMed ID: 6310399
[TBL] [Abstract][Full Text] [Related]
39. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
Bray KR; Koda JE; Gaur PK
Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
[TBL] [Abstract][Full Text] [Related]
40. Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera.
Dietel M; Arps H; Klapdor R; Müller-Hagen S; Sieck M; Hoffmann L
J Cancer Res Clin Oncol; 1986; 111(3):257-65. PubMed ID: 3460995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
